Guardion Health Sciences terminates CEO Jan Hall; effective Oct 17, 2024

Guardion Health Sciences, Inc.

Janet Hall terminated as President and CEO; remains employee through Oct 17, 2024.
Severance of ~$400,000 plus $300,000 transaction bonus from Viactiv sale.
Company expects to name interim CEO before Oct 17, 2024.
No permanent replacement announced yet; search underway.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Janet Hall

President and Chief Executive Officer

Guardion Health Sciences, Inc.

Effective: 2024-10-17
Filed: September 23, 2024, 7:59 PM ET

On September 17, 2024, Guardion Health Sciences, Inc. (the “Company”) announced the termination of Janet (“Jan”) Hall, its President and Chief Executive Officer, effective on October 17, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Janet Hall was terminated as President and Chief Executive Officer at Guardion Health Sciences, Inc..

Action: terminated
Role: President and Chief Executive Officer

Exact text from the filing

On September 17, 2024, Guardion Health Sciences, Inc. (the “Company”) announced the termination of Janet (“Jan”) Hall, its President and Chief Executive Officer, effective on October 17, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-037760

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.